PYC 2.94% 17.5¢ pyc therapeutics limited

Ann: Extension of RP11 Single Dose Study Into Multiple Dose Study, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,624 Posts.
    lightbulb Created with Sketch. 341
    we can but hope for efficacy but with no side effects. That will turn most heads. And this step brings forward any efficacy signals by the amount Hottod eluded to. Of course, we may yet get efficacy from the first dose of 75ug, but if not, this gives us the best and earliest chance we have had since the trials started and now it is earlier. I cant work out when that would be but it’s about 3 months earlier, but we will have had 2 doses as well, so….. its a big step for PYC if indeed it brings fwd measurable efficacy. Very Big.
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.